Caissa Capital Management ltd. - 20 Apr 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Issuer symbol
AVTX
Transactions as of
20 Apr 2023
Net transactions value
+$53,672
Form type
4
Filing time
24 Apr 2023, 16:32:46 UTC
Previous filing
18 Apr 2023
Next filing
27 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $15,392 +5,000 +0.39% $3.08* 1,297,700 20 Apr 2023 See Footnote (1) F1, F2
transaction AVTX Common Stock Purchase $38,280 +12,500 +0.96% $3.06* 1,310,200 24 Apr 2023 See Footnote (1) F1, F3
holding AVTX Common Stock 182,300 20 Apr 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.94 to $3.14, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.94 to $3.15, inclusive.
F4 These shares are directly owned by Mr. Golestaneh in his personal capacity.